Merck & Co., Inc. is 152.9x more valuable than Bausch Health Companies Inc. by market capitalization ($294.13 B vs $1.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHC | MRK |
|---|---|---|
| Market cap | $1.92 B | $294.13 B |
| US-listed rank | #2124 | #44 |
| Revenue (latest FY) | $10.27B | $65.01B |
| Net income (latest FY) | $157.00M | $18.25B |
| Net margin | 1.5% | 28.1% |
| P/E (trailing FY) | 12.3 | 16.1 |
| SEC filings | 2,398 | 996 |
Merck & Co., Inc. is 152.9x more valuable than Bausch Health Companies Inc. by market capitalization ($294.13 B vs $1.92 B).
In their latest fiscal years, Bausch Health Companies Inc. reported $10.27B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Bausch Health Companies Inc. and Merck & Co., Inc., or browse the full rankings.